404856006: emtricitabine (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\inhibiteur de la transférase\Reverse transcriptase inhibitor\Emtricitabine (substance)
\Substance categorized by disposition\agent antiviral\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Emtricitabine (substance)

\Drug or medicament (substance)\Anti-infective agent (substance)\agent antiviral\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\Emtricitabine (substance)

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Emtricitabine (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Emtricitabine (substance)
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Emtricitabine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Emtricitabine (substance)	est un(e) (attribut)	Reverse transcriptase inhibitor	true	Inferred relationship	Some
Emtricitabine (substance)	Has disposition (attribute)	Reverse transcriptase inhibitor (disposition)	true	Inferred relationship	Some
Emtricitabine (substance)	est un(e) (attribut)	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Emtricitabine (substance)	est un(e) (attribut)	Pyrimidine	true	Inferred relationship	Some
Emtricitabine (substance)	est un(e) (attribut)	inhibiteur de la transférase	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing bictegravir and emtricitabine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only efavirenz and emtricitabine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing only emtricitabine (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine and rilpivirine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Bictegravir and emtricitabine and tenofovir only product in oral dose form	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Efavirenz and emtricitabine and tenofovir only product in oral dose form	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 10 mg/mL oral solution	Has precise active ingredient	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 10 mg/mL oral solution	Has basis of strength substance (attribute)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	Has precise active ingredient	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet	Has basis of strength substance (attribute)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing emtricitabine (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some
Product containing emtricitabine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some
Emtricitabine 10mg/mL s/f oral solution (product)	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some
médicament contenant éfavirenz et emtricitabine et ténofovir	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some
médicament contenant emtricitabine et rilpivirine et ténofovir	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	2
Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Emtricitabine-containing product in oral dose form	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Emtricitabine (substance)	Inferred relationship	Some	1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Emtricitabine (substance)	Inferred relationship	Some	2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some	3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	Has basis of strength substance (attribute)	True	Emtricitabine (substance)	Inferred relationship	Some	3
Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form	a pour principe actif (attribut)	True	Emtricitabine (substance)	Inferred relationship	Some	1
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some	7
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	False	Emtricitabine (substance)	Inferred relationship	Some	7
Emtricitabine 10 mg/mL oral solution	a pour principe actif (attribut)	False	Emtricitabine (substance)	Inferred relationship	Some
Product containing precisely emtricitabine 200 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Emtricitabine (substance)	Inferred relationship	Some	1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	Has precise active ingredient	True	Emtricitabine (substance)	Inferred relationship	Some	3
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Emtricitabine (substance)	Inferred relationship	Some	2
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	False	Emtricitabine (substance)	Inferred relationship	Some	3
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	False	Emtricitabine (substance)	Inferred relationship	Some	3

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2148686015	Emtricitabine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2156735019	Emtricitabine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
637791000241110	emtricitabine (substance)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
808401000172117	emtricitabine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)